Development and evaluation of orally disintegrating tablets containing the mosapride resin complex

.blurhash-client-img { display: none !important; }

Open Access

|Apr 2018

Authors

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang

State Key Laboratory of Medicinal Resources, Chemistry and Molecular Engineering, Guangxi Normal University, Gui Lin

DOI: https://doi.org/10.2478/acph-2018-0017 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Language: English

Page range: 159 - 170

Accepted on: Jan 15, 2018

Published on: Apr 26, 2018

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2018 Tong Wu, Guanhua Wang, Caihong Shi, Jinghan Li, Na Zhao, Zihao Dong, Weisan Pan, Xiangrong Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.